David Bargiela

1.3k citations
30 papers · 855 indexed · h-index 17
Topics
Mitochondrial Function and Pathology (6 papers)Cancer, Hypoxia, and Metabolism (6 papers)Immune Cell Function and Interaction (6 papers)

In The Last Decade

David Bargiela

30 papers receiving 848 citations

Peers

David Bargiela
Comparison fields: 5 of 85
  • Molecular Biology 412
  • Oncology 180
  • Cancer Research 173
  • Immunology 163
  • Cellular and Molecular Neuroscience 150
Replace Lorena Travaglini with:
Lorena Travaglini Italy
Karina Balan United States
Annalinda Pisano Italy
Xiaoping Wu United States
Yongshan Mou United States
Ivan Presta Italy
Duk Joon Suh South Korea
Tong Qiao China
Anja Apel Germany
David Bargiela relative to Lorena Travaglini Italy Lorena Travaglini's profile →
Citations per field
00.5×
Lorena Travaglini · 1×
Citations per year

Countries citing papers authored by David Bargiela

Since Specialization
Citations

This map shows the geographic impact of David Bargiela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bargiela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bargiela more than expected).

Fields of papers citing papers by David Bargiela

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Bargiela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bargiela. The network helps show where David Bargiela may publish in the future.

Co-authorship network of co-authors of David Bargiela

This figure shows the co-authorship network connecting the top 25 collaborators of David Bargiela. A scholar is included among the top collaborators of David Bargiela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Bargiela. David Bargiela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 33
3 32
4 8
5 36
6 4
7 5
8 38
9 26
10 50
11 64
12 48
13 15
14 58
15 42
16 1
17 29
18 49
19 94
20 1

About David Bargiela

David Bargiela is a scholar working on Microbiology, Rehabilitation and Cancer Research, having authored 30 papers that have together received 855 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (6 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Cancer Research (173 citations), Clinical Biochemistry (59 citations) and Cellular and Molecular Neuroscience (150 citations). David Bargiela has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include Patrick F. Chinnery, Helene Rundqvist, Randall S. Johnson, Pedro Veliça, Rita Horváth, Laura Barbieri, Iosifina P. Foskolou, Pedro P. Cunha, Sara Mijwel and Stephen P. Burr. Their work appears in journals such as Brain, Neurology and Cell Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026